Regulation of the galanin system by repeated electroconvulsive seizures in mice

Journal of Neuroscience Research

Volumn 88, Issue 16, 2010, Pages 3635-3643

  Christiansen, S H ^a   Woldbye, D P D ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antidepressant; ECS; Galanin; Hippocampus; Tail suspension test

Indexed keywords

GALANIN; GALANIN RECEPTOR; GALANIN RECEPTOR 1; GALANIN RECEPTOR 2; IMIPRAMINE; IODINE 125;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DRUG EFFICACY; ELECTROCONVULSIVE STIMULATION; ELECTROCONVULSIVE THERAPY; EPILEPTIC DISCHARGE; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYRIFORM CORTEX; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE; SEIZURE THRESHOLD; TAIL FLICK TEST; TONIC CLONIC SEIZURE;

ANIMALS; BRAIN; DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROSHOCK; GALANIN; GENE EXPRESSION REGULATION; MALE; MICE; SEIZURES; TISSUE DISTRIBUTION;

EID: 78049435806     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22517     Document Type: Article

References (54)

1. Agasse F, Bernardino L, Kristiansen H, Christiansen SH, Ferreira R, Silva B, Grade S, Woldbye DP, Malva JO. 2008. Neuropeptide Y promotes neurogenesis in murine subventricular zone. Stem Cells 26: 1636-1645.
2. Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, Bukhman YV, Young TA, Charles V, Palfreyman MG. 2004. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24: 2667-2677.
3. Barr AM, Kinney JW, Hill MN, Lu X, Biros S, Rebek JJr, Bartfai T. 2006. A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neurosci Lett 405: 111-115.
4. Bolwig TG, Madsen TM. 2007. Electroconvulsive therapy in melancholia: the role of hippocampal neurogenesis. Acta Psychiatr Scand Suppl p 130-135.
5. Cheung CC, Hohmann JG, Clifton DK, Steiner RA. 2001. Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus. Neuroscience 103: 423-432.
6. 35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice. J Neurosci Res 84: 1282-1291.
7. Cryan JF, Holmes A. 2005. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4: 775-790.
8. Cryan JF, Mombereau C, Vassout A. 2005. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29: 571-625.
9. Depczynski B, Nichol K, Fathi Z, Iismaa T, Shine J, Cunningham A. 1998. Distribution and characterization of the cell types expressing GALR2 mRNA in brain and pituitary gland. Ann N Y Acad Sci 863: 120-128.
10. Drevets WC. 2001. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11: 240-249.
11. Ebert U, Rundfeldt C, Loscher W. 1995. Development and pharmacological suppression of secondary afterdischarges in the hippocampus of amygdala-kindled rats. Eur J Neurosci 7: 732-741.
12. Fetissov SO, Jacoby AS, Brumovsky PR, Shine J, Iismaa TP, Hokfelt T. 2003. Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout mice. Epilepsia 44: 1022-1033.
13. Gale K. 1992. Subcortical structures and pathways involved in convulsive seizure generation. J Clin Neurophysiol 9: 264-277.
14. Harrison PJ. 2002. The neuropathology of primary mood disorder. Brain 125: 1428-1449.
15. Holmes PV, Crawley JN. 1996. Olfactory bulbectomy increases prepro-galanin mRNA levels in the rat locus coeruleus. Brain Res Mol Brain Res 36: 184-188.
16. Jalink K, Moolenaar WH. 2010. G protein-coupled receptors: the inside story. Bioessays 32: 13-16.
17. Jarosik J, Legutko B, Unsicker K, von Bohlen Und HO. 2007. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy. Exp Neurol 204: 20-28.
18. 125I]Galanin binding in brain of wildtype, and galanin- and GalR1-knockout mice: strain and species differences in GalR1 density and distribution. Neuroscience 131: 407-421.
19. Kanter-Schlifke I, Toft SA, Ledri M, Kuteeva E, Hokfelt T, Kokaia M. 2007. Galanin gene transfer curtails generalized seizures in kindled rats without altering hippocampal synaptic plasticity. Neuroscience 150: 984-992.
20. Kaplan LM, Spindel ER, Isselbacher KJ, Chin WW. 1988. Tissue-specific expression of the rat galanin gene. Proc Natl Acad Sci U S A 85: 1065-1069.
21. Karelson E, Langel U. 1998. Galaninergic signalling and adenylate cyclase. Neuropeptides 32: 197-210.
22. Kokaia M, Holmberg K, Nanobashvili A, Xu ZQ, Kokaia Z, Lendahl U, Hilke S, Theodorsson E, Kahl U, Bartfai T, Lindvall O, Hokfelt T. 2001. Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc Natl Acad Sci U S A 98: 14006-14011.
23. Kuteeva E, Wardi T, Lundstrom L, Sollenberg U, Langel U, Hokfelt T, Ogren SO. 2008. Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level. Neuropsychopharmacology 33: 2573-2585.
24. Lin EJ, Richichi C, Young D, Baer K, Vezzani A, During MJ. 2003. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development. Eur J Neurosci 18: 2087-2092.
25. Liu X, Gershenfeld HK. 2003. An exploratory factor analysis of the tail suspension test in 12 inbred strains of mice and an F2 intercross. Brain Res Bull 60: 223-231.
26. Loscher W, Ebert U. 1996. The role of the piriform cortex in kindling. Prog Neurobiol 50: 427-481.
27. Lu X, Barr AM, Kinney JW, Sanna P, Conti B, Behrens MM, Bartfai T. 2005a. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci U S A 102: 874-879.
28. Lu X, Mazarati A, Sanna P, Shinmei S, Bartfai T. 2005b. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity. Neuropeptides 39: 147-152.
29. Lu X, Ross B, Sanchez-Alavez M, Zorrilla EP, Bartfai T. 2008. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides 42: 387-397.
30. Maier T, Guell M, Serrano L. 2009. Correlation of mRNA and protein in complex biological samples. FEBS Lett 583: 3966-3973.
31. Mathe AA. 1999. Neuropeptides and electroconvulsive treatment. J ECT 15: 60-75.
32. Mazarati AM, Liu H, Soomets U, Sankar R, Shin D, Katsumori H, Langel U, Wasterlain CG. 1998. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. J Neurosci 18: 10070-10077.
33. Mazarati AM, Hohmann JG, Bacon A, Liu H, Sankar R, Steiner RA, Wynick D, Wasterlain CG. 2000. Modulation of hippocampal excitability and seizures by galanin. J Neurosci 20: 6276-6281.
34. Mazarati A, Langel U, Bartfai T. 2001. Galanin: an endogenous anticonvulsant? Neuroscientist 7: 506-517.
35. Mazarati A, Lu X, Kilk K, Langel U, Wasterlain C, Bartfai T. 2004. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. Eur J Neurosci 19: 3235-3244.
36. Mazarati A, Lundstrom L, Sollenberg UE, Shin D, Langel U, Sankar R. 2006. Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: the effects of subtype selective agonists and the role of G-protein mediated signaling. J Pharmacol Exp Ther 318: 700-708.
37. McCown TJ. 2006. Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo. Mol Ther 14: 63-68.
38. Mikkelsen JD, Woldbye DP. 2006. Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation. J Psychiatr Res 40: 153-159.
39. Nikisch G, Mathe AA. 2008. CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy. Eur Psychiatry 23: 356-359.
40. Ogren SO, Kuteeva E, Hokfelt T, Kehr J. 2006. Galanin receptor antagonists: a potential novel pharmacological treatment for mood disorders. CNS Drugs 20: 633-654.
41. Pagnin D, Pini S, Cassano GB. 2004. Efficacy of ECT in depression: a meta-analytic review. J ECT 20: 13-20.
42. Painsipp E, Wultsch T, Edelsbrunner ME, Tasan RO, Singewald N, Herzog H, Holzer P. 2008. Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav 7: 532-542.
43. Paxinos G, Franklin K. 2001. The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
44. Porsolt RD, Bertin A, Jalfre M. 1977. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229: 327-336.
45. Ressler KJ, Mayberg HS. 2007. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 10: 1116-1124.
46. Ripoll N, David DJ, Dailly E, Hascoet M, Bourin M. 2003. Antidepressant-like effects in various mice strains in the tail suspension test. Behav Brain Res 143: 193-200.
47. Sackeim HA. 1999. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT 15: 5-26.
48. Sackeim HA, Decina P, Prohovnik I, Portnoy S, Kanzler M, Malitz S. 1986. Dosage, seizure threshold, and the antidepressant efficacy of electroconvulsive therapy. Ann N Y Acad Sci 462: 398-410.
49. Sheline YI. 2003. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 54: 338-352.
50. Stenfors C, Theodorsson E, Mathe AA. 1989. Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain. J Neurosci Res 24: 445-450.
51. Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85: 367-370.
52. Swanson CJ, Blackburn TP, Zhang X, Zheng K, Xu ZQ, Hokfelt T, Wolinsky TD, Konkel MJ, Chen H, Zhong H, Walker MW, Craig DA, Gerald CP, Branchek TA. 2005. Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci U S A 102: 17489-17494.
53. Walf AA, Frye CA. 2006. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31: 1097-1111.
54. Wang D, Noda Y, Tsunekawa H, Zhou Y, Miyazaki M, Senzaki K, Nabeshima T. 2007. Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behav Brain Res 178: 262-273.